{"meta":{"query_hash":"33b245e19481","filters":{"venue":"Journal of Molecular Chemistry."},"cohort_total":1,"direct_labels_cover":0,"predictions_cover":1,"exported":1,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/33b245e19481","api":"https://metacan.xera.ac/api/v1/cohort?venue=Journal+of+Molecular+Chemistry."},"results":[{"id":"W4410047027","doi":"10.62110/sciencein.jmc.2025.1206","title":"Novel small molecule drugs approved by FDA in 2024 for cancer therapy","year":2025,"lang":"en","type":"article","venue":"Journal of Molecular Chemistry.","topic":"Glutathione Transferases and Polymorphisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Cancer therapy; Cancer drugs; Cancer; Medical physics; Internal medicine","score_opus":0.007613639462595399,"score_gpt":0.2513824018588955,"score_spread":0.24376876239630008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410047027","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94763225,0.01650803,0.032595046,0.0015757327,0.00022257974,0.00023478415,0.000077874225,0.0000041489484,0.0011495423],"genre_scores_gemma":[0.9908549,0.0017996723,0.0016040035,0.0015099017,0.00015911832,0.00006458314,0.000062560415,0.000043591146,0.0039016448],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99886245,0.000019896686,0.00043929505,0.00026266716,0.00013944681,0.00027623758],"domain_scores_gemma":[0.9993295,0.00001651415,0.00015754614,0.00022996594,0.00017499209,0.000091459566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020857692,0.0002158742,0.00027494197,0.000047408892,0.000034887158,0.000030210223,0.0003212629,0.0002056047,0.00003438415],"category_scores_gemma":[0.00004800029,0.00020251903,0.00029300383,0.00014646718,0.000048137597,0.0000038142796,0.00003250436,0.0001998409,3.1094865e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045403227,0.00020317499,0.00007901218,0.00006563046,0.00016619248,0.000008450465,0.0000321175,0.00012986617,0.9908252,0.00001783632,0.005239921,0.0027785623],"study_design_scores_gemma":[0.0031061429,0.000114974944,0.000026211079,0.00007235409,0.000036219502,0.00001919623,0.00005272432,0.00005344631,0.93281597,0.00007168126,0.06344339,0.00018768005],"about_ca_topic_score_codex":0.000044545293,"about_ca_topic_score_gemma":0.0000095434925,"teacher_disagreement_score":0.05820347,"about_ca_system_score_codex":0.000037507598,"about_ca_system_score_gemma":0.0002778349,"threshold_uncertainty_score":0.82584864},"labels":[],"label_agreement":null}]}